<DOC>
	<DOCNO>NCT00292591</DOCNO>
	<brief_summary>The purpose study determine effectiveness vitamin D supplementation pregnancy start begin second trimester . Mothers randomize one three vitamin D dose group : 400 , 2,000 4,000 international unit per day . It hypothesize high dose regimen result good vitamin D status woman regardless ethnicity race .</brief_summary>
	<brief_title>Evaluation Vitamin D Requirements During Pregnancy</brief_title>
	<detailed_description>The prevalence hypovitaminosis D reproductive age African-American woman occur rate &gt; 40 % . Two factor contribute public health problem : inadequate DRI vitamin D avoidance sun exposure/use sunscreen . This startle rate hypovitaminosis D require DRI vitamin D pregnancy evaluate detailed manner . The Cochrane Library ( 2002 ) release report state insufficient data evaluate effect vitamin D supplementation pregnancy . Recently , safety prolong supplementation 25x 's DRI ( 10,000 IU/day ) demonstrate nonpregnant adult . It essential determine dose vitamin D require eliminate hypovitaminosis D pregnancy provide fetus/neonate adequate vitamin D store development growth , particularly darkly pigment individual . The aim research proposal , , determine efficacy , effectiveness , safety maternal vitamin D supplementation ( function ethnicity UV exposure ) prevention hypovitaminosis D pregnant mother fetus/neonate . We hypothesize darkly pigment mother require substantially high oral supplementation vitamin D eliminate hypovitaminosis D compare Caucasian counterpart . We propose comprehensive clinical trial test hypothesis . Mothers 12 week ' gestation randomize one three vitamin D treatment group : 1 . Control , 400- , 2 . 2,000- , 3 . 4,000 IU/day continue throughout pregnancy . Calcium vitamin D homeostasis skeletal remodel mother monitor closely throughout pregnancy . Bone density mother measure 12 week ' gestation one-month postpartum . Follow-up growth skeletal integrity assessment infant perform birth , 1 , 6 12 month stratify infant feeding regime . Through propose study , prevalence hypovitaminosis D among mother , develop fetus neonate , utility maternal therapeutic intervention vitamin D mother fetus/infant assess .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Women within age 1645 year 2 . In good general health 3 . Less 12 week pregnant ( base last menstrual period ) 1 . Mothers preexist type I type II diabetes 2 . Mothers preexist hypertension 3 . Mothers preexist parathyroid disease uncontrolled thyroid disease 4 . Mothers multiple fetus ( e.g. , twin , triplet , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>pregnancy</keyword>
	<keyword>bone mineral density</keyword>
</DOC>